Tag archive

immuno-oncology

PMR Projects Global Immuno-Oncology Therapy Market Value to Hit the US $ 1O Bn Mark in 2019 End

in Pharmaceutical News
Press Release: PMR Projects Global Immuno-Oncology Therapy Market Value to Hit the US $ 1O Bn Mark in 2019 End

The immuno-oncology therapy has shown excellent results in various clinical trials and in patients being treated with immune-oncology therapy. Immuno-oncology therapies can leverage patients’ immune system and re-program the same to attack cancer cells, providing a safe and effective alternative. There has been an increasing demand for immuno-oncology therapy as several traditional methods used in the treatment of cancer such as chemotherapy, radiation therapy, and surgery, etc. carry the risk of side effects, and have limited effectiveness as they tend…

Keep Reading

You might be interested in

Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies

in Pharmaceutical News
Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies in autoimmune disease and immuno-oncology

Pathios Therapeutics (“Pathios”), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery (“Sygnature”), jointly announce a strategic partnership to accelerate Pathios’ drug discovery and development programmes. As part of the agreement, Pathios and Sygnature will collaborate on an integrated drug discovery programme against a novel G Protein-Coupled Receptor (GPCR) target. Specifically, Sygnature are providing their industry leading expertise in GPCR bioscience and medicinal chemistry to expand Pathios’ current…

Keep Reading

You might be interested in

Go to Top